FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in[...]
11/16/2023 | Press release | Distributed by Public on 11/16/2023 19:56
Please select the service you want to use:
Smartlinks | Americanas SA | News | Crime and Judiciary | Crime | Corporate Crime | Technology | Internet | E-Commerce | Finance | Security Markets | Security Markets | Company News | Investment Funds | Retail | E-Commerce | Travel, Leisure and Recreation Industry | Tour Operators and Travel Agencies | Securities Issuers | E-Commerce Companies | Sao Paulo Stock Exchange (B3) | OTC Markets
Copyright ©2006-2023 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact